Stock listing
A3ERZ4 Stock Price, News, Filings & Events — Dianthus Therapeutics, Inc.
Selected listing: A3ERZ4 · LSX · EUR · DE
This page tracks Dianthus Therapeutics, Inc.'s A3ERZ4:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3ERZ4:LSX. A3ERZ4:LSX is the stock-level entry point for investors researching Dianthus Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3ERZ4:LSX
- Asset type
- Stock
- Market cap
- $5.92B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Dianthus Therapeutics, Inc. A3ERZ4:LSX stock context
This page tracks Dianthus Therapeutics, Inc.'s A3ERZ4:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3ERZ4:LSX. A3ERZ4:LSX is the stock-level entry point for investors researching Dianthus Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Dianthus Therapeutics, Inc.
Dianthus Therapeutics to Participate in Three Investor Conferences During September
September 1, 2026
Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
August 3, 2026
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
July 2, 2026
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
June 3, 2026
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 2, 2026
Research Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A3ERZ4:LSX.
Dianthus Therapeutics, Inc. company profile
View the public company page for Dianthus Therapeutics, Inc. on 6ix.
Dianthus Therapeutics, Inc. news
Read company news and market updates connected to Dianthus Therapeutics, Inc..
Dianthus Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Dianthus Therapeutics, Inc..
Alternate listings
DNTH:NASDAQ
US · USD
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.
87E:GETTEX
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.
87E:TRADEGATE
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.
A3ERZ4:LS
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.
DNTH:BOATS
US · USD
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.
87E:DUS
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.
87E:FWB
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.
87E:MUN
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.
87E:SWB
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is A3ERZ4:LSX.